Articles tagged "Outcome"

2016 American Transplant Congress
Effect of Modifying Life Support Withdrawal Practices on Outcomes of Donation After Circulatory Death in Liver Transplantation: A Meta-Analysis.
Y. Cao,^1,2 S. Shahrestani,³ H. Chew,^2,4 M. Crawford,⁵ P. Macdonald,^1,2,4 J. Laurence,^3,5,7 W. Hawthorne,^3,6 K. Dhital,^1,2,4 H. Pleass.^3,5,6
¹Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; ²Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; ³Sydney Medical School, University of Sydney, Sydney, NSW, Australia; ⁴Cardiac Transplant Unit, St. Vincent's Hospital, Sydney, NSW, Australia; ⁵Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia; ⁶The Department of Surgery, Westmead Hospital, Sydney, NSW, Australia; ⁷Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Aim. Donor warm ischaemic time is identified as the main risk factor for poor outcomes in liver transplantation using donation after circulatory death (DCD) compared…
2016 American Transplant Congress
Does Rising MELD Score Convey Worse Liver Transplant Outcome?
A. Rahnemai-Azar, J. Perkins, M. Montenovo, T. Pearson, R. Bakthavatsalam, S. Rayhill, A. Dick, J. Reyes, L. Sibulesky.
Surgery, University of Washington, Seattle, WA.
Since February 2002, the Model for End-Stage Liver Disease (MELD) score has been used to allocate liver allografts in the U.S. The aim of this…
2016 American Transplant Congress
Induction Therapy in Low Risk African American Kidney Transplant Recipients: Donor Factors.
F. Al Ammary,¹ S. Bae,¹ A. Massie,¹ N. Dagher,¹ E. King,¹ A. Wiseman,² D. Segev.¹
¹JHU, Baltimore; ²CU, Denver.
African Americans (AA) are at a higher risk of acute rejection and graft loss compared to non-AA kidney transplant (KT) recipients. Guidelines specify induction choices…
2016 American Transplant Congress
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.
M. Konerman,¹ D. Fritze,² R. Weinberg,³ E. Spengler,¹ C. Sonnenday,² P. Sharma.¹
¹Hepatology, Univ of Michigan, Ann Arbor, MI; ²Transplantation Surgery, Univ of Michigan, Ann Arbor, MI; ³Cardiology, Univ of Michigan, Ann Arbor, MI.
Purpose: Cardiovascular (CV) events remain a major source of morbidity and mortality following liver transplantation (LT). This review evaluates the incidence of and risk assessment…
2016 American Transplant Congress
Clinical Risk Factors for the Recurrence of Clostridium difficile Infection (CDI) in Solid Organ Transplant Recipients (SOTR).
Y. Natori, M. Shiotsuka, L. Oen, E. Renner, L. Singer, J. Kim, H. Ross, D. Kumar, C. Rotstein, A. Humar, S. Husain.
Multi-Organ Transplant, University Health Network, Toronto, ON, Canada.
Introduction:CDI is a common complication in SOTR. Recurrence may occur after treatment of the initial episode. However, the clinical risk factors of the recurrence of…
2016 American Transplant Congress
Tool to Assess Risk of Non-Adherence in Renal Transplant Candidates.
T. Kaiser,¹ K. Daley,² L. Dick,² L. Deye,² N. Parrish,² J. Huff,² A. Govil,¹ B. Abu Jawdeh,¹ G. Mogilishetty,¹ R. Alloway,¹ E. Woodle.¹
¹Medicine, University of Cincinnati, Cincinnati; ²Transplant, University of Cincinnati Medical Center, Cincinnati, OH.
Nonadherence (NA) is likely the primary driver of late graft loss and was found to occur in 59% of renal transplant (RTx) patients at our…
2016 American Transplant Congress
Mortality and Graft Loss Attributable to Readmission Following Kidney Transplantation.
E. King, M. Bowring, L. Kucirka, M. McAdams-DeMarco, A. Massie, D. Segev.
Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.
BACKGROUND: Early hospital readmission (EHR) following kidney transplantation (KT) is independently associated with graft loss and mortality. Prior work assumes that this association is constant…
2016 American Transplant Congress
Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States: Epidemiology, Outcomes, and Costs.
A. Mathur, Y.-H. Chang, D. Steidley, N. Khurmi, N. Katariya, A. Singer, W. Hewitt, K. Reddy, A. Moss.
Transplant Center, Mayo Clinic, Phoenix.
Background: Cardiovascular disease (CVD) is a leading cause of post-liver transplant death, and variable care patterns may affect outcomes. We aimed to describe epidemiology, outcomes,…
2016 American Transplant Congress
Pulmonary Hypertension in Renal Transplant Candidates: A Systematic Review and Meta-Analysis of the Available Evidence.
A. Moza,¹ A. Khan,² R. Prashar,³ S. Khan,¹ S. Khouri,¹ S. Vetteth,¹ D. Malhotra,¹ M. Rees,¹ G. Moukarbel,¹ J. Ortiz.¹
¹Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH; ²Cardiovascular Medicine, University of Louisville, Louisville, KY; ³Nephrology and Transplantation, Henry Ford Medical Center, Detroit, MI.
Background: Pulmonary hypertension (PHT) is common in patients with end stage renal disease (ESRD). Moderate to severe PHT is a strong independent predictor of mortality…
2016 American Transplant Congress
Outcomes of Donor Nephrectomy (DN) in the Obese.
O. Serrano,¹ A. Bangdiwala,² D. Vock,³ E. Minja,¹ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ T. Pruett,¹ A. Matas,¹ R. Kandaswamy.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics and Bioinformatics Core, Masonic Cancer Center, Minneapolis, MN; ³Biostatistics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: In an effort to address the critical organ shortage and rising obesity rates, the criteria for live kidney donation (LKD) have been expanded to…